biotech pivot
Biotech interest shifting from obesity ‘halo’ to other areas like oncology and blood cancers
obesity drugs; biotech pivot; investment trends; Novartis; leukemia; obesity halo; sector rotation; autoimmune; oncology
Actionable Insights Powered by AI
obesity drugs; biotech pivot; investment trends; Novartis; leukemia; obesity halo; sector rotation; autoimmune; oncology